These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27656543)

  • 1. Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma.
    Mishra R; Khurana R; Mishra H; Rastogi M; Hadi R
    J Clin Diagn Res; 2016 Aug; 10(8):XC01-XC03. PubMed ID: 27656543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.
    McDonald AM; Jacob R; Dobelbower MC; Kim RY; Fiveash JB
    Acta Oncol; 2013 Aug; 52(6):1181-8. PubMed ID: 23544356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer.
    Jain N; Sharma R; Sachdeva K; Kaur A; Sudan M
    J Med Phys; 2022; 47(2):141-144. PubMed ID: 36212213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
    Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
    Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
    Ghannam AA; Khedr RA
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial.
    Yadav BS; Dahiya D; Gupta M; Gupta A; Oinam AS; Khare S; Irrinki S; Robert N; Sakaray YR; Nagaraj SS; Kumari R
    Lancet Reg Health Southeast Asia; 2024 May; 24():100392. PubMed ID: 38550605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis.
    Jones CM; Spencer K; Hitchen C; Pelly T; Wood B; Hatfield P; Crellin A; Sebag-Montefiore D; Goody R; Crosby T; Radhakrishna G
    Clin Oncol (R Coll Radiol); 2019 Jun; 31(6):356-364. PubMed ID: 30737068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
    Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
    Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy.
    Yang JF; Lee MS; Lin CS; Chao HL; Chen CM; Lo CH; Fan CY; Tsao CC; Huang WY
    Medicine (Baltimore); 2016 Mar; 95(11):e3113. PubMed ID: 26986158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Versus Hypofractionated Radiation Therapy for Localized or Locally Advanced Prostate Cancer: A Systematic Review and Meta-analysis along with Therapeutic Implications.
    Datta NR; Stutz E; Rogers S; Bodis S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):573-589. PubMed ID: 29280452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genitourinary and gastrointestinal toxicity among patients with localized prostate cancer treated with conventional versus moderately hypofractionated radiation therapy: systematic review and meta-analysis.
    Carvalho ÍT; Baccaglini W; Claros OR; Chen FK; Kayano PP; Lemos GC; Weltman E; Kuban DA; Carneiro A
    Acta Oncol; 2018 Aug; 57(8):1003-1010. PubMed ID: 29882448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Remouchamps V; Wallace M; Sharpe M; Fayad J; Tyburski L; Letts N; Kestin L; Edmundson G; Pettinga J; Goldstein NS; Wong J
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1247-53. PubMed ID: 14630258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.